THERMO FISHER SCIENTIFIC INC.

TMO NYSE CIK: 0000097745

Company Information

Industry Measuring & Controlling Devices, NEC
SIC Code 3829
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 168 THIRD AVENUE, WALTHAM, MA, 02451
Mailing Address 168 THIRD AVENUE, WALTHAM, MA, 02451
Phone 7816221000
Fiscal Year End 1231
EIN 042209186

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
4 Insider stock transaction report March 12, 2026 View on SEC
3 Initial insider ownership report March 10, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC
4 Insider stock transaction report March 2, 2026 View on SEC

Annual Reports

10-K February 26, 2026
  • Thermo Fisher Scientific delivered strong financial results with $43.5 billion revenue (12% increase) and $7.8 billion net income (10% increase), achieving $19.85 diluted EPS.
  • The company maintains a dominant market position across four core segments, fueled by strategic acquisitions and significant R&D investment ($1.6 billion).
View Analysis

Material Events

8-K Acquisition March 24, 2026
High Impact
  • Completed $2.6 billion cash acquisition of Clario Holdings, Inc.
  • Integration of decentralized clinical trial solutions into the Biopharma Services division.
View Analysis

Insider Trading

STRONG SELL 5 insiders 41 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3829)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.